ifosfamide has been researched along with Lymphangioendothelioma, Malignant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, Y | 1 |
| Teramoto, Y | 1 |
| Sato, S | 1 |
| Fujisawa, Y | 1 |
| Yamada, K | 1 |
| Yamamoto, A | 1 |
| Malhaire, JP | 1 |
| Labat, JP | 1 |
| Simon, H | 1 |
| Le Maux, H | 1 |
| Spindler, P | 1 |
| Lucas, B | 1 |
| Lamezec, B | 1 |
2 other studies available for ifosfamide and Lymphangioendothelioma, Malignant
| Article | Year |
|---|---|
Long-term control of pleural metastasis in Stewart-Treves syndrome with single-agent chemotherapies followed by maintenance chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Doxorubicin; Drug Administration Schedule | 2015 |
One case of Stewart-Treves syndrome successfully treated at two years by chemotherapy and radiation therapy in a 73-year-old woman.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic | 1997 |